Last remaining seats to the Jpost 2017 Annual Conference! Get your special offer now

Former Teva CEO Eli Hurvitz dies of cancer at 79

November 22, 2011 10:10

Ex-CEO of leading generics company and Israel Prize winner succumbs to cancer.

Teva Founder Eli Hurvitz.

Eli Hurvitz 311. (photo credit:Wikimedia Commons)

Teva pharmaceuticals former CEO Eli Hurvitz died of cancer at the age of 79 Monday night at Sheba Hospital in Tel Hashomer.

Having served as the company's CEO and chairman, Hurvitz retired for medical reasons in 2009.

Be the first to know - Join our Facebook page.

Teva to set up Israeli drug development VC fund
Teva to power factory with natural gas

President Shimon Peres, who heard of Hurvitz's death while on route to Vietnam, said "his loss is a personal loss to me and an even greater loss to the State of Israel." He went on to call Hurvitz a "unique human being" and an unpretentious, modest individual, who through Teva had contributed to the saving of millions of lives.

After learning of his death, Prime Minister Binyamin Netanyahu said of Hurvitz: "He was among the great manufacturers to arise in the state of Israel."

"There was no better ambassador for Israeli entrepreneurship and spirit," Netanyahu concluded.

Finance Minister Yuval Steinitz added that Hurvitz turned a small company into a global giant, calling him a visionary in every sense of the word.

Hurvitz won the Israel Prize in 2002 for his contributions to the state.

Teva is the largest generic drug manufacturer in the world, and the 15th largest company listed on the NASDAQ.
Relevant to your professional network? Please share on Linkedin

  • israel prize
  • drugs
  • cancer
  • Share this article via
    from around the web
    Related Content
    August 31, 2014
    Rioting resumes throughout east Jerusalem Saturday night


    Top Stories
    Israel Weather
    • 13 - 27
      Beer Sheva
      14 - 23
      Tel Aviv - Yafo
    • 13 - 24
      16 - 23
    • 22 - 33
      16 - 31